Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease
Abstract We investigated the association between body weight variability and the risks of cardiovascular disease and mortality in patients with nonalcoholic fatty liver disease (NAFLD) using large-scale, nationwide cohort data. We included 726,736 individuals with NAFLD who underwent a health examin...
Guardado en:
Autores principales: | Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Tracey G. Simon, Andrew T. Chan, Seong Gyu Hwang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9731fb4038c74659bb692043c7f4feee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea
por: Goh Eun Chung, et al.
Publicado: (2021) -
Body weight gain rather than body weight variability associated with increased risk of nonalcoholic fatty liver disease
por: Eun Ju Cho, et al.
Publicado: (2021) -
Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B
por: Jihye Lim, et al.
Publicado: (2021) -
Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH).
por: Xuerong Wen, et al.
Publicado: (2021) -
Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Tae Hyung Kim, et al.
Publicado: (2021)